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“실패를 걱정하지 말고, 먼저 부지런히 목표를 향하여 노력하라. 
노력한 만큼 보상을 받을 것이다. 쉬운 길, 편안한 길로 가는 
사람은 성공의 묘미를 못 느낀다. 어려움 없이 성취되는 것은 
하나도 없다. -노만 V. 필.”  
 
대학원 박사과정에 들어와서 연구실 책꽂이에 꽂혀 있던 이우주 
선생님의 자서전 한 권이 오늘의 저를 있게 해준 삶의 지표가 된 
듯 합니다. 시련을 실패로 착각하거나 실패가 두려워 도전하기를 
꺼려하는 것은 어쩌면 나약한 인간의 본성일지 모릅니다. 삶과 
실험이 힘들 때마다, 제 자신의 한계에 부딪쳐 도망치고 싶을 
때마다, 제게 언제나 희망이라는 단어와 최선을 다하면 이루지 
못할게 없다는 신념을 가지게 해준 이 책이 제게 제 자신과의 
싸움에서 조금이나마 이겨 나갈 수 있는 힘이 된 것 같습니다.  
구체적인 목표가 있는 사람은, 조금 돌아가더라도 확고한 신념과 
목표가 있다면 그 꿈을 이룰 수 있다고 생각합니다. 그러나 그 
꿈을 이루기 위해서는 그 길을 올바르게 갈 수 있도록 인도해 주는 
안내자와 나침반이 필요하다고 생각합니다. 그런 면에서 저는 신의 
은총으로 훌륭한 안내자를 만나서 너무나도 운이 좋은 사람입니다. 
박사과정 5년 동안, 너무나도 부족한 저를 언제나 믿어주시고 
기회를 주신 김혜영 교수님, 약리학 교실원으로서의 자부심을 
심어주신 김경환 교수님께 먼저 머리숙여 마음깊이 감사의 인사를 
드리고 싶습니다. 가는 길이 힘들어 포기하고 싶을 때도, 제 
자신을 믿지 못해 모든 것이 실패라고 생각했을 때도, 저를 
감싸주시고 제게 올바른 길로 갈 수 있는 지혜와 자세를 가르쳐 
주신 교수님께 더 좋은 결과를 보여 드리지 못한 것 같아 너무나 
송구스럽습니다. 하지만 두 분 교수님의 지도가 있었기에 어떠한 
역경에서도 꿋꿋히 헤쳐나갈 수 있는 지혜와 용기를 가지고 헤쳐 
나갈 수 있게 되었다고 말씀드리고 싶습니다. 
 
저의 연구에 언제나 소홀함을 지적해주시고 격려하여주신 안영수 
교수님, 삶에 있어서의 목표와 용기를 언제나 강조해주신 김동구 
교수님, 저의 연구에 부족한 부분을 지적하여주시고 좋은 
아이디어를 주신 이민구 교수님, 늘 미소로 대해주시고 항상 좋은 
말씀해주시는 박경수 교수님, 진심으로 감사드립니다. 
 
 심사위원으로서 제 논문이 나오기까지 많은 도움과 조언을 주시고 
격려하여 주신 정재복 교수님, 송시영 교수님, 허만욱 교수님께 
머리 숙여 감사의 말씀을 전합니다. 늘 밝은 얼굴로 대해주시는 
서정택 교수님, 늘 새로운 정보를 소개하고 열정적인 김철훈 
교수님, 특히 이 분이 없었으면 제가 실험을 제대로 수행하지 
못했을 저를 지도해주신 임주원 교수님께 감사드립니다. 제 논문이 
나오기까지 많은 도움을 주신 정혜연 선생님과 서정연 선생, 정말 
감사합니다. 
  
약리학교실에서 더불어 즐겁게 지낸 교실선생들에게도 
감사합니다. 강한 리더십으로 팀을 꾸렸던 추상희 선생, 박사입학 
동기로서 도움이 많이 되었던 유지훈 선생과 서지혜 선생, 많이 
배려해주는 주경돈 선생, 실험실 생활에 적응되도록 많이 도와준 
송지연 선생, 예쁘고 씩씩했던 혜연이, 궂은 일에도 열심히 
해주었던 종화, 모든 일에 열심히 하고 항상 웃는 졸업동기가 될 
동생 같은 보람이, 컴퓨터도 잘하는 동휘, 잘 해낼거라 기대되는 
유망주 순옥이에게 감사의 말을 전합니다. 좋은 의견을 
제시해주었던 이진우 선생님, 김주영 선생님, 최지하 선생님에게 
감사 드리며, 이성희 선생님과 이정호 선생님에게도 감사합니다. 
언제나 차분하고 든든했던 남궁완과 윤신영 선생, 밝은 얼굴의 
이지현과 이정남 선생, 늘 친절하고 도움 많이 준 윤정이, 무슨 
말이든 잘 이해해주었던 형진이에게도 감사드립니다. 예영민 
선생님, 곽진오 선생, 성복, 정수, 지헌영 선생, 재석, 현우, 기호, 
임아영 선생님, 미경, 재연씨, 영신씨, 배우리, 우영씨, 좀 더 
넓은 세상으로 나아간 이쁜 효선이, 모두에게도 감사드리며 그동안 
잘 못해준 것이 남아 이쉽습니다. 교실선생님들이 잘 지내도록 
언제나 도움 주는 임종수 선생님, 언제나 유쾌한 건태씨, 좋은 
연구 성과를 내기 위해서 열심히 하는 별아 엄마, 부탁하면 
거절않고 도움 많이 준 동생 같은 민선자에게 감사의 말을 
전합니다.  
2년여 동안 같이 생활해 온 식품영양학과 식구들에게도 감사의 
말을 전합니다. 책임감 많은 언제나 리더인 성희, 든든하고 성격 
좋은 상용, 시원시원한 경숙이, 착실한 선은이, 새내기 윤미, 
엉뚱발랄한 막내 지현이에게도 감사합니다. 
  
 생명에 대한 연구 분야에 처음으로 기회를 주시고 지도해주신 
조기승 교수님께 너무 감사드리며, 췌장에 대하여 임상적인 정보를 
주신 서정훈 선생님 감사드립니다. 
  항상 믿어주시고 제 편이 되어주시는 어머니, 어머니의 지원이 
아니었으면 제가 이 자리에 있지 못했을 거라 생각됩니다. 동생 
성원이, 혜욱이, 언제나 대견스러운 조카 범석이게도 감사의 말 
전합니다. 
 늘 격려하시고, 힘들때 항상 챙겨주시는 장모님, 조언을 잘 
해주는 형님 황일호씨, 동서내외인 양정봉씨와 황수옥씨, 외조카인 
창우, 창인에게도 감사의 말 전합니다.  
 늘 우정을 함께 해주는 친구, 기성이, 선화, 을주, 양미, 
준이에게도 감사의 말을 전하며, 대학 같은 과와 어우림 동아리의 
선배, 동기, 후배에게도 감사의 말을 전합니다. 
마지막으로 공부하는 남편을 뒷바라지하며 고생하는 저의 소중한 
인연 황수양씨에게 감사드립니다. 제 아내를 만나지 못했다면 
지금의 제가 없었을 것입니다. 힘들 때에도, 항상 행복을 더 많이 
가져다주는 소중한 딸 경민이에게 고맙다는 말을 전합니다. 
 
이제 마무리할 대학원 생활에 아직도 많은 미련과, 좀 더 잘할 
수 있었을 것이라는 후회가 남습니다. 이제 졸업이라는 하나의 
계단을 올라왔습니다. 아직도 제가 올라갈 많은 계단이 남아 
있습니다. 저를 아껴주시고 사랑해 주신 모든 분들께 감사 인사를 
드리며, 이제 또 하나의 계단을 오르기 위해 또 노력하고자 합니다. 
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Abstract  
Role of Angiotensin II Type 2 Receptor and VEGF-D in Cerulein-
Induced Inflammation of Pancreatic Acinar Cells 
 
Jang Won LEE 
 
Department of Medical Science, 
The Graduate School, Yonsei University 
 
(Directed by Professor Kyung Hwan KIM) 
 
 
Cerulein-induced pancreatitis model is similar to human acute edematous 
pancreatitis. Their common characteristics include dysregulation of the 
digestive enzyme production, aberrant cytoplasmic vacuolization, death of 
acinar cells, edema formation, and infiltration of inflammatory cells into the 
pancreas. 
The present study was designed to elucidate the role(s) of VEGF-D and 
angiotensin II type 2 receptor in inflammatory signaling in cerulein-stimulated 
rat pancreatic AR42J cells. Stimulation of AR42J cells by cerulein caused 
differential expression of several membrane proteins. Among these proteins, 
level of VEGF-D was increased by cerulein treatment. Angiotensin II type 2 
receptor, another renin-angiotensin system component, is localized and 
associated with cerulein-induced inflammation in pancreatic acinar cells. In 
this study, it was shown that angiotensin II type 2 receptor interacts with 
VEGF-D. 
Cytokine expression was inhibited by treatment with ERK1/2 or MEK1 
 - 2 - 
antagonists as well as by transfection with dominant negative genes such as 
IκB mutant, RasN-17 (for Ras) or TAM67 (for c-Jun) in cerulein-stimulated 
AR42J cells. This indicates that NF-κB, AP-1 and ERK1/2 are involved in 
cerulein-induced inflammation. Furthermore, cerulein-induced activation of 
NF-κB and AP-1 was inhibited by antagonist of ERK1/2. This suggests that 
activation of NF-κB as well as that of AP-1 is mediated by ERK signaling 
pathways. 
Cerulein induced translocation of VEGF-D to the cell surface, and increased 
its interaction with angiotensin II type 2 receptor. Antisense-oligonucleotide 
for VEGF-D suppressed activation of NF-κB and AP-1 as well as IL-6 
expression in cerulein-stimulated AR42J cells. This demonstrates that VEGF-
D activates expression of cytokines through activation of AP-1 and NF-κB. 
Additionally, expression of cytokines was inhibited by angiotensin II type 2 
receptor antagonist but not by VEGF receptor antagonist in cerulein-
stimulated AR42J cells. In conclusion, VEGF-D mediates the inflammatory 
signaling of pancreatic acinar cells through interaction with angiotensin II 
type 2 receptor. 
 
 
 
 
 
 
 
 
Key words: VEGF-D, Angiotensin II type 2 receptor, cerulein, acute 
pancreatitis 
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Role of Angiotensin II Type 2 Receptor and VEGF-D in Cerulein-
Induced Inflammation of Pancreatic Acinar Cells 
 
Jang Won LEE 
 
Department of Medical Science, 
The Graduate School, Yonsei University 
 
(Directed by Professor Kyung Hwan KIM) 
 
 
I. INTRODUCTION 
 
Acute pancreatitis is a multifactorial disease associated with the release of 
digestive enzymes into the pancreatic interstitium and to the systemic 
circulation1-3. The production and release of cytokines are increased in acute 
pancreatitis, which can ultimately lead to the deleterious local and systemic 
effects. Despite considerable progress in understanding pathophysiology of 
pancreatitis, the mechanisms of the development of this disease remain 
obscure. A number of animal models in experimental pancreatitis have been 
well developed. Administration of supramaximal dose of cerulein is one of the 
best characterized and widely studied experimental pancreatitis models. 
Supramaximal dose of cerulein results in dysregulation of the production and 
secretion of digestive enzymes. It also causes cytoplasmic vacuolization and 
death of acinar cells, edema formation, and infiltration of inflammatory cells 
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into the pancreas4-6. Cerulein induces reactive oxygen species (ROS) 
production, cytokine expression and apoptosis in rat pancreas and in 
pancreatic acinar cell line6, 36-38. However the pathogenic mechanism of 
pancreatitis has not been clarified. Over the past several years, evidences have 
accumulated on the involvement of inflammatory mediators in the 
development of pancreatitis7, 8. Systemic levels of interleukin (IL)-6 and IL-8 
are increased in patients with acute pancreatitis and correlated with the 
severity of the disease. There is considerable evidence that pro-inflammatory 
cytokines such as tumor necrosis factor (TNF)-α and IL-1β play a central role 
in acute pancreatitis and may mediate the systemic complication of acute 
pancreatitis8, 16, 17. IL-1β and TNF-α act as proximal mediators, and induce 
production of other mediators including IL-6 and IL-88. The cellular 
mechanism of these inflammatory molecules involves activation of 
transcription factors such as NF-κB and AP-118. Activation of NF-κB in the 
pancreas has recently been demonstrated in rat cerulein-pancreatitis. 
Inhibition of NF-κB activation resulted in a decrease in the expression of 
cytokines16, 19, 20. AP-1 as well as NF-κB represents early response 
transcriptional complexes essential for the gene expression of inflammatory 
molecules. MAP kinases are serine-threonine-directed kinases originally 
identified as being activated by mitogens. They are activated by a variety of 
stimuli including growth factors, cytokines, neurotransmitters, hormones, 
extracellular matrix molecules, and cell stress21, 36, 37. MAP kinases regulate a 
number of cellular processes including gene transcription, protein translation, 
metabolism, and the function of the cytoskeleton. Also, MAP kinases are 
involved in control of cell growth, differentiation, survival, and apoptosis. 
Currently, there are five independent MAP kinase cascades, but information 
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on their function in the pancreas and other differentiated cells is limited to the 
cascades leading to the extracellular signal-regulated kinase1/2 (ERK1/2), c-
Jun-NH2-terminal kinases1/2 (JNK1/2), and p38 MAP kinase22. 
To understand early pathophysiologic mechanism of acute pancreatitis, 
differentially expressed membrane-proteins were analyzed in cerulein-
stimulated AR42J cells52. Among these membrane-proteins, VEGF-D was 
increased by cerulein. VEGF family is involved in renin-angiotensin system 
components. It activates ERK1/223 and its human orthologue shares 84% 
identity. It was named VEGF-D because its primary sequence is most similar 
to VEGF-C. Both VEGF-C and VEGF-D are recognized by VEGF receptor-2 
and VEGF receptor-3, which are present on endothelial cells32-34.  
Recently, it was reported that renin-angiotensin system components are 
present in isolated acinar cells as well as AR42J cell line24, 26, 27. Interestingly, 
pancreatic inflammatory conditions such as pancreatitis, hypoxia, and fibrosis 
can upregulate the renin-angiotensin system components in the pancreas, 
leading to further inflammation and tissue injury23, 34. This suggests that these 
may play an important role in the signal transduction of pancreatitis-
induction24. Also, recently, it was reported that VEGF-D expression is related 
to ERK1/2 activation in several cells25-27, 34 and the inflammation of these 
cells is induced by interaction of VEGF-D with angiotensin II type 2 receptor 
28, 29
. However, the role of VEGF-D in signaling pathway of pancreatitis has 
not known yet. The present study was designed to elucidate whether VEGF-D 
is associated with angiotensin II type 2 receptor, and involved in cytokine 
expression in cerulein-stimulated AR42J cells. The roles of VEGF-D and 
angiotensin II type 2 receptor in inflammation of cerulein- stimulated 
pancreatic acinar cells were also investigated. 
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II. MATERIALS AND METHODS 
 
1. Cell line 
The rat pancreatic acinar AR42J cells (pancreatoma, ATCC CRL 1492) were 
cultured in Dulbecco’s modified Eagle’s medium (Sigma, St. Louis, MO, 
USA) supplemented with 20% fetal bovine serum (GIBCO-BRL, Granad 
Island, NY, USA) and antibiotics (100 U/ml penicillin and 100 g/ml 
streptomycin) in a 10% CO2 and 90% O2. Induction of acute pancreatitis is 
achieved by stimulation of supramaximal concentration of cerulein (10-8 M). 
 
2. Preparation of cytosolic and membrane fraction 
The AR42J cells were trypsinized and washed with phosphate buffered 
saline (PBS) and then centrifuged at 500 rpm for 5min. The cells were 
resuspended with lysis buffer containing 10 mM Tris buffer pH 7.4, 50 mM 
NaCl, 1 mM EDTA, 50 µM leupeptin, 50 µM aprotitin, and 1 mM 
phenylmethylsulfonylfloride. And cells were lysed by drawing the cells 
through a 1 ml syringe with several rapid strokes. Nuclei and intact cells were 
sedimented down at 2,000 x g for 10 min. Membrane and cytosolic fraction 
were separated further by centrifugation at 100,000 x g for 1 hr. The protein 
content was determined by using a BCA protein assay kit50 (Bio-rad 
laboratories, Hercules, CA, USA). 
 
3. Transfection  
 Subconfluent AR42J cells were plated in 10-cm culture dishes. To observe 
signaling of cytokine expression, the cells were transfected for 24 hr with 10 
µg of pcDNA, IκB mutant, RasN-17 or TAM67 expression plasmid constructs 
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using DOTAP (Boehringer Mannheim, Mannheim, Germany). On the other 
hand, to investigate signaling by VEGF-D, the cells were transfected for 24 hr 
with 500 µM of VEGF-D sense (5’-CAAAATGTA TGGAGAGTGGG-3’) or 
500 µM of antisense (5’-CCCACTCTCCATACATTTTG-3’) 
oligodeoxynucleotide (GIBCO-BRL, Granad Island, NY, USA). 
 
4. Reverse transcription-polymerase chain reaction 
Total RNA is isolated from cells by guanidine thiocyanate extraction 
method40. cDNA was synthesized with 2 µg total RNA. Polymerase chain 
reaction (PCR) was carried out with 160 ng cDNA and cytokine (IL-1β, IL-6, 
TNF-α) primer. Total volume of PCR was adjusted to 20 µl with 10 mM Tris-
HCl (pH 8.3), 50 mM KCl, 2 mM MgCl2, 0.1 mM dNTP, and 0.6U Tag 
polymerase. The internal control (GAPDH) is coamplified with a cytokine. 
Expression level of cytokine mRNA is normalized to that of housekeeping 
gene (GAPDH) in the same sample. The sequence for IL-1β primer is 5’-
TCCTAGGAA ACAGCAATGGTCG-3’(forward primer) and 5’-
TTCATCCCATACACACGGACAAC-3’(reverse primer). The sequence for 
IL-6 primer is 5’-CTGGTCTTCTGGAGTTCCGTT TC -3’(forward primer) 
and 5’-CATAGCACACTAGGTTTGCCGAG-3’(reverse primer). The 
sequence for TNF-α is 5’-CTCAAAGACAACCAACTGGTGGTAC-
3’(forward primer) and 5’-ACAGAGCAATGACTCCAAAGTAGACC-
3’(reverse primer). GAPDH sequence is 5’-ACCACAGTCCATGCCATCAC-
3’(forward primer) and 5’-TCCACCACC CTGTTGCTGTA-3’(reverse 
primer). PCR amplification was performed employing the following 
conditions: denaturizing at 95°C for 30 sec, annealing at 60°C for 30 sec, and 
extension at 72°C for 30 sec for a total of 32 cycles. Five-micro liter samples 
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from each 25 µl PCR product were removed and analyzed by electrophoresis 
and UV transillumination on 1.5 % agarose gel involving 0.5 µg/ml ethidium 
bromide. 
 
5. Enzyme-linked immunosorbent assay 
 The medium was immediately removed from cultures, and centrifuged at 
15,000 x g to remove cell pellets and cellular debris. Levels of IL-6, IL-1β 
and TNF-α in medium were determined using enzyme-linked immunosorbent 
assay (ELISA) kit (Bio-source Inc., Canton, MA, USA) according to the 
manufacturer's instructions. 
 
6. Western blotting analysis 
Proteins in cell lysate, cytosolic fraction or membrane fraction were 
separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
(SDS–PAGE containing 10% polyacrylamide). After electrophoresis, proteins 
were transferred onto nitrocellulose membrane (Amersham, Arlington Heights, 
IL, USA) by semidry blotting system (Bio-rad laboratories, Hercules, CA, 
USA). After transfer of proteins onto nitrocellulose membrane, non-specific 
sites were blocked by a solution of Tris-buffered saline with Tween 20 (TBS-
T: 50 mM Tris, 150 mM NaCl, 0.02 % (v/v) Tween-20, pH 7.4), containing 
5 % (w/v)  nonfat dry milk, for 2 hr at room temperature with gentle 
agitation. The nitrocellulose membrane was then incubated with specific 
antibody at a concentration of 0.2 µg/ml (1:1000) in TBS-T containing 5 % 
(w/v) nonfat-dry-milk for 12 hr at 4 °C. The nitrocellulose membrane was 
washed with TBS-T. Following the incubation of the nitrocellulose membrane 
with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG for 2 hr 
(1:2000 dilution in TBS-T containing 5 % (w/v) nonfat-dry-milk), the 
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nitrocellulose membrane was washed eight times for 10 min with TBS-T. 
Immunoreactive proteins were visualized by enhanced chemiluminescence 
(Amersham, Arlington Heights, IL, USA). 
 
 
7. Electrophoretic mobility shift assay  
Enzyme-linked immunosorbent assay (EMSA) was performed with nuclear 
extracts prepared from non-stimulated cells or cerulein-stimulated cells. 
Briefly, 30 µg of nuclear extract was incubated with 32P-labeled probes in 
binding buffer (20 mM HEPES (pH 7.4), and 5 mM EDTA, 300 mM KCl, 
25 % glycerol) for 40 min at room temperature. γ-32P-labeled probes 
contained the following double-stranded oligonucleotides, which were 
generated by a kinase reaction with polynucleotide kinase and [γ-32P] ATP 
(Amersham, Piscataway, NJ, USA) NF-κB (5’–
AGTTGAGGGGACTTTCCCAGGC-3’), AP-1 (5’-
CGCTTGATGACTCAGCCGGAA-3’). Reaction mixtures were analyzed on 
6% polyacrylamide gels containing 0.25M TBE buffer (22.5 mM tris, 22.5 
mM borate and 500 µM EDTA, pH 8.0). The gel was then dried for 1 hr at 
80 °C and exposed to Kodak film (Eastman Kodak Co., Rochester, NY, USA) 
at 80 °C. 
 
8. Proteomics 
A. Isoelectric focusing and two-dimensional electophoresis separation 
Three hundred µg of membrane fraction isolated from cells were adsorbed 
onto a 17 cm IPG strip (pH 5-8), and then electrophoresed on an isoelectric 
focusing (IEF) cells (Bio-Rad Laboratories, Hercules, CA, USA) for 70,000 
Vh at 20 oC. Following IEF the IPG strips were subjected to equilibration for 
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15 min in equilibration buffer (375 mM Tris-HCl, pH 8.8, containing 6 M 
urea, 2 % w/v SDS, 20 % v/v glycerol, and 2 % w/v dithiothreitol). Strips 
were then re-equilibrated for 15 min in the same buffer containing 2.5 % w/v 
iodoacetamide in place of dithiothreitol. In all cases, molecular weight 
separation was achieved with 8 % polyacrylamide gel using Protean II xi cell 
gel SDS-PAGE system (Bio-Rad Laboratories, Hercules, CA, USA). 
 
B. Coomassie brilliant blue-G 250 staining and image analysis 
Proteins in gels were Coomasie brilliant blue (CBB) G-250 stained. After 
overnight fixation (50 % ethanol, 2 % w/v phosphoric acid), gels were washed 
three times for 20 min in double-distilled water and incubated for at least 48 
hr in a solution containing 34 % methanol, 17 % ammonium sulfate, 3 % w/v 
phosphoric acid and CBB G-250 powder (0.1 %). The stained gels were 
digitalized using a GS 690 Imaging densitometer (Bio-Rad Laboratories, 
Hercules, CA, USA) at a resolution of 400 x 400 dpi. The digitalized images 
from both the CBB G-250 stained gels (from non-stimulated cells and 
cerulein-stimulated cells) were analyzed using the two-dimensional 
electrophoresis gel analysis program PDQuest (Bio-Rad Laboratories, 
Hercules, CA, USA). A comparison report of qualitative and quantitative 
differences of the samples for each set of data was then generated. 
 
C. In-gel digestion 
In-gel digestion of proteins from CBB G-250 stained gels was performed as 
follows. Spots were excised to 1-2 mm2 slices using a blade, destained with 
freshly prepared 15 mM potassium ferricyanide/ 50 mM sodium thiosulfate, 
washed with 25 mM ammonium bicarbonate/ 50 % acetonitrile, and dried in a 
SpeedVac Plus SC100A vacuum concentrator (Savant, Holbook, NY, USA). 
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The dried gel pieces were rehydrated with 3-10 µl of 20 ng/ml trypsin solution, 
the solution volume being enough for the dried gel to be reswelled. Digestion 
was continued at 37 oC for 14-18 hr. Tryptic peptides were first extracted 
using 5 % trifluoroacetic acid (Bio-Rad Laboratories, Hercules, CA, USA) for 
40 oC for 1 hr, then 2.5 % trifluoroacetic acid /50 % acetonitrile at 30 oC for 1 
hr. The extracted solutions were mixed in an eppendorf tube, and dried in a 
vacuum concentrator. 
 
D. Proteomic analysis 
The peptide mixture was solubilized with 0.5 % trifluoroacetic acid for MS 
analysis. MS was performed on a Micromass M@LDI-TOF (Manchester, UK) 
with saturated α-cyano-4-hydroxy-trans-cinnamic acid solution in 0.1% 
trifluoroacetic acid / 50% acetonitrile as matrix. Mass spectra were externally 
calibrated with autodigest peaks of trypsin (MH+: 906.505 Da, 1020.504 Da, 
1153.574 Da, 2163.057 Da, and 2273.160 Da). The peptide mass maps 
produced by MALDI-TOF MS were searched against the published databases 
by means of the MS-Fit module in Protein Prospector and Mascot.  
 
9. Immunoprecipitation 
It is investigated whether VEGF-D is associated with angiotensin II type 2 
receptor using immunoprecipitation (IP) method. AR42J cells were stimulated 
with cerulein for 15, 30 and 60 min. The cells were washed with PBS and 
scraped. The cells were centrifugated at 1200 x g for 10 min and the 
supernatant was removed. The cells were lysated with 1 ml IP buffer 
containing 100 mM NaCl, 20 mM Tris buffer (pH 7.4), 1 mM EDTA, 1 mM 
EGTA, 0.1 % SDS, 1 % Nonidet P-40, 0.5 % deoxycholate, 50 µM leupeptin, 
50 µM aprotitin, and 1 mM phenylmethylsulfonylfloride and incubated for 30 
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min on ice. The samples were centrifugated at 7500 x g for 30 min. 
Supernatant was transfered to new tube and its protein concentration was 
determined. 1 mg of protein was added to new tube and then incubated with 
anti- angiotensin II type 2 receptor antibody and protein A/G Plus-agarose 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4 oC. After 
centrifugation, the pellet was washed with IP buffer and was used for western 
blotting analysis for VEGF-D. 
 
10. Immunocytochemistry 
Immunocytochemistry against cell type–specific markers was performed on 
AR42J cell cultures. AR42 J cells were cultured at cerulein for 1 hr, fixed in 
cold methanol for 10 min and washed three times with PBS. The cells were 
then incubated with polyclonal primary antibodies. Primary antibodies used 
were rat anti–rabbit VEGF-D (4 µg/ml; Santa Cruz Biotechnology, Santa Cruz, 
CA, USA) and rat anti–goat angiotensin II type 2 receptor (4 µg/ml; Santa 
Cruz Biotechnology, Santa Cruz, CA, USA). After incubation of blocking 
solution (containing 2 % goat serum, 1 % BSA and 0.1 % gelatin in PBS) for 
1 hr, cells were incubated for 1 hr at room temperature with secondary 
antibody solution containing FITC-conjugated secondary antibody (final 
concentration; 2 µg/ml in blocking solution) and rhodamine-conjugated 
secondary antibody (final concentration; 3 µg/ml in blocking solution) 
purchased from Jackson Immuno-Research Laboratories (USA). Samples 
were again washed in PBS and counterstained with mounting medium and 
cover-slipped. The cells incubated with FITC- and rhodamine-conjugated 
secondary antibodies were examined with laser scanning confocal microscope 
(Leica TCS-NT, Heidelberg, Germany) and photographed.  
Optical filters used for exitation were 450-490 nm for FITC (green) and 510-
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560 nm for rhodamine (red). 
 
11. Immnoprecipitation for the protein on cell surface 
To immunoprecipitate the populations of VEGF-D on the cell surface, cells 
were cultured with cerulein for 30 min, 1 hr, or 2 hr. Cultures were washed 
with cold PBS, and then incubated with an anti-VEGF-D antibody (2 µg/ml in 
2 % bovine serum albumin in PBS) or normal goat IgG (2 µg/ml in 2 % 
bovine serum albumin in PBS) for 1 hr on ice with gentle shaking. The 
unbound antibody was removed with cold PBS and cells were lysed by adding 
extraction buffer containing 150 mM NaCl, 10 mM Tris-HCl buffer (pH 7.4), 
1 mM EDTA, 1 mM EGTA, 0.5 mM phenylmethylsufonylfloride, 1 % 
Nonidet P-40, and 0.5 % deoxycholate. The insoluble material was separated 
by centrifugation (13,000 x g for 30 min at 4 °C). The clarified supernatant 
was incubated with 50 µl of protein A/G Plus-agarose per a sample for 
overnight at 4 oC. The beads were washed with extraction buffer time, and 
resuspended in 2x SDS sample buffer46. Levels of VEGF-D were determined 
by western blotting analysis using anti-VEGF-D antibody. 
 
12. Statistical analysis 
 Each experiment was performed at least three times. Results were 
expressed as means ± standard error of four separate experiments. Analysis of 
variance (ANOVA) followed by Newman-Keul’s test was used for statistical 
analysis47. P<0.05 was considered statistically significant. 
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III. RESULTS 
 
1. Cerulein induces cytokine expression and activates NF-κB 
and AP-1 in AR42J cells 
Cerulein increased the mRNA and protein levels of IL-6, IL-1β and TNF-α 
in AR42J cells over 0~4 hr of treatment (Fig.1A and B). The EMSA data 
showed that NF-κB and AP-1 were activated by cerulein within 30 min (Fig. 
1C). 
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Fig.1. Expression of cytokines and activation of NF-κB and AP-1 in cerulein-
stimulated AR42J cells. Cells were cultured in the absence or presence of cerulein 
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for the indicated times. (A) mRNA levels of cytokines were measured by RT-PCR. 
mRNA expression levels were normalized by internal control (GAPDH) in the same 
sample. (B) Levels of cytokines in medium were determined by ELISA. (C) DNA-
binding activities of NF-κB and AP-1 in nuclear extracts were determined by EMSA 
analysis 
 
 
2. Cytokine expression is mediated by Ras, AP-1, and NF-κB 
in cerulein-stimulated AR42J cells 
Transfection with Ras N-17, TAM67 or IκB mutant gene significantly 
suppressed cerulein-induced IL-6 expression and, to a lesser extent, IL-1β and 
TNF-α expression (Fig. 2A-D). Cerulein-induced DNA binding activities of 
NF-κB and AP-1 were significantly reduced by transfection with Ras N-17 
and TAM67 (Fig. 2E). Transfection with IκB mutant gene attenuated NF-κB 
activation but not that of AP-1. These data shows that DNA binding activity of 
NF-κB is regulated by AP-1 and Ras in cerulein-stimulated AR-42J cells and 
suggests possible crosstalk between AP-1, NF-κB, and MAP kinase in 
cytokine expression in AR42J cells. 
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 C                                 D 
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Fig. 2. Expression of cytokines and activation of NF-κB and AP-1 in cerulein-
stimulated AR42J cells transfected with IκB mutant, Ras N-17 or TAM 67. 
Before stimulation of cerulein, cells were transfected with IκB mutant, Ras N-17, or 
TAM 67 for 24 hr. (A) For the analysis of cytokine mRNA expression, cells were 
stimulated with cerulein for 3 hr. Cytokine mRNA expression levels were normalized 
by internal control GAPDH in the same sample. (B) Cytokine production was 
measured after 24 hr treatment with cerulein and compared with non-treated group. 
*P<0.05 vs wild none or pcDNA (without cerulein) (C) After 30 min stimulation with 
cerulein, activation of NF-κB and AP-1 was determined by EMSA analysis. 
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3. Cytokine expression is mediated by MAP kinases in 
cerulein-stimulated AR42J cells 
To clarify the role of activated p38 and ERK1/2 in cerulein-induced 
cytokine expression, cells were treated with SB203580, U0126 or PD98059 
prior to cerulein treatment. Cerulein-induced expression of cytokine mRNA 
was suppressed by treatment of U0126 or PD98059 (Fig. 3A). Cerulein-
induced DNA binding activities of NF-κB and AP-1 were also reduced by 
U0126 and PD98059 (Fig. 3B). This result suggests that expression of 
cytokines and activations of NF-κB and AP-1 are mediated by ERK1/2 in 
cerulein-stimulated AR42J cells. 
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Fig. 3. Effect of ERK or p38 antagonist on expression of cytokines and activation 
of NF-kB and AP-1 in cerulein-stimulated AR42J cells. SB203580, U0126 and 
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PD98059 are inhibitors for p38, ERK1/2, and MEK1, respectively. Before stimulation 
of cerulein, cells were treated with antagonist for 10 min. (A) For cytokine mRNA 
expression, cells were incubated in absence or presence of cerulein for 3 hr. Cytokine 
mRNA expression levels were normalized by internal control GAPDH in the same 
sample. (B) After 30 min stimulation with cerulein, activation of NF-κB and AP-1 
was determined by EMSA analysis. 
 
 
 
4. Cerulein induces differential expression of membrane 
proteins of AR42J cells  
Membrane proteins play important roles in various cellular processes 
including signal transduction. Thus, the relationship between differentially 
expressed membrane proteins and induction of acute pancreatitis may be the 
early important pathologic event in inflammatory cytokine expression. 
Membrane proteins were extracted from non-stimulated cells or cerulein-
stimulated cells. Isoelectric focusing analysis and two-dimensional 
electophoresis separation were carried out to determine proteins differentially 
expressed by cerulein. Differentially expressed membrane proteins were 
identified by peptide mass fingerprinting (Fig. 4). Mascot search using the 
peptide mass fingerprinting data indicated that the differentially expressed 
proteins are protein disulfide isomerase precursor, actin beta, MASP-2 protein, 
Hsp 60, phosphatidylinositol transfer protein, actin gamma, isocitrate 
dehydrogenase 3 (NAD+) alpha, acidic ribosomal protein PO, tumor-
associated Ca2+ signal transducer 1, seven in absentia 1A, ER protein 29, ATP 
synthase subunit d (Table 1). 
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Fig. 4.  Proteomic analysis of membrane proteins in non-stimulated cells or 
cerulein-stimulated AR42J cells. Two-dimensional gel map was derived from non-
stimulated cells or cerulein-stimulated cells for 1 hr. Three hundred µg of membrane 
protein isolated from cells was applied to pH 5-8 linear IPG strips (17 cm), and with 
8 % linear vertical SDS-PAGE as the second dimension. The gel was visualized by 
CBB-G staining. Several proteins marked above are those that were differentially 
expressed between non-stimulated cells and cerulein-stimulated cells. 
 
Table 1. List of membrane proteins changed by cerulein in AR 42J cells.  
 
 
 
 
 
 
 
 
 
Spot No.                           Protein name                 Protein database            Predicted     Predicted %                Change
accession No.          M r                    pI Coverage         by cerulein
R01
R02
R03
R04
R05
R06
R07
R08
R09
Protein disulfide isomerase A3 precursor 
Actin beta
Protein disulfide isomerase A3 precursor
Protein disulfide isomerase A3 precursor
VEGF-D
MASP-2 protein
Heat shock protein 60
Heat shock protein 60
Phosphatidylinositol transfer protein
1352384
71620
129731
2501206 M
15430279
6689087
11560024 M
11560024 M
16758568 M
56624
41751
56952
47221
37107
36951
60966
60966
31450
5.9
5.3
4.8
4.9
5.9
6.0
5.9
5.9
6.4
56.0
50.0
22.0
32.0
32.0
37.0
42.0
46.0
25.0
Decreased
Increased
Increased
Decreased
Increased
Increased
Increased
Increased
Increased
R11
R12
R13
R14
R15
R16
R17
R22
Actin, gamma
Isocitrate dehydrogenase 3 (NAD+) alpha
Acidic ribosomal protein PO
Tumor-associated Ca2+ signal Transducer 1
Seven in absentia 1A
Endoplasmic retuclum protein 29
ATP synthase subunit d
Protein disulfide isomerase A3 precursor
4501887 M
16758446 M
11693176 M
25742698 M
18266718 M
16758848 M
9506411 M
1352384
41793
39614
34216
35208
32017
28575
18764
56624
5.3
6.5
5.9
6.0
6.7
6.2
6.2
5.9
46.0
44.0
64.0
35.0
30.0
51.0
58.0
46.0
Decreased
Decreased
Decreased
Decreased
Decreased
Decreased
Decreased
Decreased
Kd
Non-stimulated cell                                Cerulein-stimulated cell
5                              PI                             8
105
75
50
35
160
25
IEF IEF
SD
S-
PA
G
E
SD
S-
PA
G
E
5                              PI                             8
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5. Cytokine expression is mediated by angiotensin II type 2 
receptor but not by VEGF receptor in cerulein-stimulated 
AR42J cells 
To investigate whether activation of angiotensin II type 2 receptor and/or 
VEGF receptor are involved in cerulein-induced inflammation, cells were 
stimulated with an angiotensin II type 2 receptor or a VEGF receptor 
antagonist prior to cerulein-stimulation. Cerulein-induced cytokine expression 
was suppressed by an angiotensin II type 2 receptor antagonist but not by 
VEGF receptor antagonist (Fig. 5). This result suggests that cerulein-induced 
cytokine expression is mediated by angiotensin II type 2 receptor but not by 
VEGF receptor. It is possible that VEGF-D may mediate cerulein-induced 
inflammation through interacting with angiotensin II type 2 receptor because 
VEFG-D was known to bind with angiotensin II type 2 receptor as well as 
VEGF receptor. 
 
 
 
 
 
 
Fig. 5. Effects of angiotensin II type 2 or VEGF receptor antagonist on IL-6 
mRNA expression in cerulein-stimulated AR42J cells. For IL-6 mRNA expression, 
cells were treated with antagonists for 15 min prior to 3hr stimulation with cerulein. 
Angiotensin II type 2 receptor antagonist (AT2R ant) is PD123319, and VEGF 
receptor antagonist (VEGFR ant) is total subtype of VEGF receptor’s antagonist. 
Cytokine mRNA expression levels were normalized by internal control GAPDH in 
the same sample. 
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6. Cerulein induces VEGF-D expression  
To determine whether cerulein induces VEGF-D expression, the level of 
VEGF-D in cerluein-stimulated cells was determined using western blotting 
analysis. Level of VEGF-D was significantly increased after 30 min of 
cerulein stimulation whereas that of angiotensin II type 2 receptor was 
unchanged. 
 
 
 
 
 
 
 
 
 
Fig. 6. VEGF-D expression in cerulein-stimulated AR42J cells. Cells were 
stimulated with cerulein at the indicated times. Levels of angiotensin II type 2 
receptor and VEGF-D in whole cell lysates were determined by western blotting 
analysis using specific antibodies.  
 
 
7. VEGF-D interacts directly with angiotensin II type 2 
receptor in cerulein-stimulated AR42J cells 
To investigate whether the VEGF-D is associated with activation of 
angiotensin II type 2 receptor in cerulein-stimulated AR42J cells, it was 
examined whether VEGF-D directly binds to angiotensin II type 2 receptor 
using immunoprecipitation method. VEGF-D was detected in anti- 
angiotensin II type 2 receptor immunoprecipitates in cerulein-stimulated 
AT2R
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VEGF-D
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AR42J cells. This result indicates that angiotensin II type 2 receptor interacts 
with VEGF-D in cerulein-stimulated AR42J cells. 
 
 
 
 
 
 
 
 
Fig. 7.  Interaction of VEGF-D with angiotensin II type 2 receptor in cerulein-
stimulated AR42J cells. The whole lysate was prepared from the cells at the 
indicated times and was immunoprecipitated for angiotensin II type 2 receptor using 
anti- angiotensin II type 2 receptor antibody. Level of VEFG-D in 
immunoprecipitates was determined by western blot using anti-VEGF-D antibody. 
 
 
8. Membrane translocation of VEGF-D is increased in 
cerulein-stimulated AR42J cells 
To demonstrate the membrane translocation of VEGF-D by cerulein, level of 
VEGF-D in cytosolic and membrane fractions from non-stimulated or 
cerulein-stimulated cells were determined by western blotting. Level of 
VEGF-D in membrane was increased between 30 min and 60 min while that 
of VEGF-D in cytoplasm was decreased (Fig. 8A). This was confirmed with 
immunocytochemistry assay (Fig. 8B). This indicates that membrane 
translocation of VEGF-D is increased in cerulein-stimulated AR42J cells. 
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Fig. 8. Translocalization of VEGF-D in cerulein-stimulated AR42J cells. (A) 
AR42J cells were cultured in the absence or presence of cerulein. Cells were collected 
at indicated times. After isolation of membrane and cytosolic fractions from cells, 
levels of VEGF-D and angiotensin II type 2 receptor in membrane and cytosolic 
fractions were determined by western blotting analysis. (B) The cells were cultured in 
the absence or presence of cerulein for 1 hr. Cells were incubated with anti- 
angiotensin II type 2 receptor or VEGF-D antibody, washed with PBS and then 
incubated with FITC-conjugated (green) or rodamine-conjugated (red) secondary 
antibody. 
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9. VEGF-D is translocated to cell surface in cerulein-
stimulated AR42J cells 
 It was investigated whether VEGF-D is translocated to cell surface by 
cerulein-stimulation. VEGF-D in cell surface was immunoprecipitated using 
anti-VEGF-D antibody and then detected by western blotting analysis. VEGF-
D in cell surface was increased by cerulein (Fig. 9). This indicates that VEGF-
D is translocated to cell surface by cerulein.  
 
 
 
 
 
 
 
Fig. 9. Immunoprecipitation of VEGF-D in cell surface. AR42J cells were 
cultured in the absence or presence of cerulein for various time periods. The intact 
cells were incubated with normal goat IgG or an anti-VEGF-D antibody (2 µg/ml in 
2% bovine serum albumin in PBS) for 60 min on ice with gentle shaking. VEGF-D in 
cell surface was immunoprecipitated with an anti-VEGF-D antibody as described in 
Materials and Methods. Immunoprecipitates was prepared in parallel with non-
immune IgG. The immunoprecipitate were subjected to western blotting analysis 
using anti-VEGF-D antibody. 
 
 
10. DNA binding activation, cytokine expression, and MAP 
kinase phosphorylations are mediated by VEGF-D in 
cerulein-stimulated AR42J cells  
To determine the role of VEGF-D in cerulein-induced inflammation, 
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antisense-oligodeoxynucleotide for VEGF-D was transfected into cells. 
Antisense-oligodeoxynucleotide for VEGF-D suppressed activation of NF-κB 
and AP-1 (Fig. 10) as well as mRNA expression of IL-6 (Fig. 11) in cerulein-
stimulated AR42J cells. Additionally, antisense-oligodeoxynucleotide for 
VEGF-D suppresses MAP kinases phosphorylation in cerulein-stimulated 
cells (Fig. 12). 
 
 
 
 
 
 
 
 
 
Fig. 10. Activation of NF-κB and AP-1 in cerulein-stimulated AR42J cells 
transfected with antisense-oligodeoxynucleotide for VEGF-D. The cells were 
transfected with 500 µM sense(S)- or antisense(AS)-oligodeoxynucleotide for VEGF-
D and then cultured in the absence or presence of cerulein for 30 min. DNA binding 
activities for f NF-κB and AP-1 were determined by EMSA. 
 
 
 
 
 
 
Fig. 11. IL-6 mRNA expression in cerulein-stimulated AR42J cells transfected 
with antisense-oligodeoxynucleotide for VEGF-D. The cells were transfected with 
500 µM sense(S)- or antisense(AS)-oligodeoxynucleotide for VEGF-D using DOTAP 
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reagent and then cultured in the absence or presence of cerulein for 3 hrs. Level of IL-
6 mRNA was determined by RT-PCR. The internal control (GAPDH) was 
coamplified. IL-6 mRNA expression level were normalized to that of housekeeping 
gene GAPDH in the same sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12. MAP kinases phosphorylation in cerulein-stimulated AR42J cells 
transfected with antisense-oligodeoxynucleotide for VEGF-D. The cells were 
transfected with 500 µM sense(S)- or antisense(AS)-oligodeoxynucleotide for VEGF-
D and then cultured in the absence or presence of cerulein for 15 min. Levels of 
phosphorylated or nonphosphorylated forms of ERK1/2, JNK1/2 and p38 were 
determined by western blotting analysis. 
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IV. DISCUSSION 
 
AR42J is a pancreatic acinar cell line obtained from primary culture of 
isolated rat pancreatic acinar cells after induction with azaserine. Despite a 
few disadvantages like short survival period or high baseline cytokine 
expression and p38 activation, AR42J is widely used to study pancreatic 
exocrine system because it is the only cell line which maintains distinctive 
characteristics of pancreatic acinar cells such as synthesis/secretion of 
digestive enzymes and expression profile of major receptors. 
Cytokines which are produced in pancreatic acinar cells induce 
inflammatory cell infiltration into pancreas, producing an inflammatory 
response. The cellular mechanism regulating these inflammatory molecules 
involves activation of transcription factors such as NF-κB and AP-118, 19. Our 
group previously reported that expression of inflammatory cytokines was 
mediated by cerulein-activated NF-κB and AP-1 in pancreatic acinar cells51. 
In present study, expression of IL-6, TNF-α, and IL-1β was suppressed by 
dominant negative mutant of NF-κB, AP-1 and Ras in cerulein-stimulated 
AR42J cells. This demonstrates that the expression of inflammatory cytokines 
is mediated by NF-κB, AP-1 and Ras in cerulein-stimulated AR42J cells. The 
activation of NF-κB was inhibited by dominant negative mutant of AP-1 
whereas that of AP-1 was not inhibited by dominant negative mutant of NF-
κB. This suggests that activation of NF-κB may be mediated by AP-1 and Ras 
in cerulein-stimulated AR-42J cells. Additionally, ERK1/2 inhibitor 
suppressed cerulein-induced activation of both NF-κB and AP-1. This result 
suggests that activation of NF-κB and AP-1 should be mediated by ERK1/2 in 
cerulein-stimulated pancreatic acinar cell. Several investigators reported that 
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activation of AP-1 is mediated by ERK1/2. It was also known that the active 
ERK1/2 directly phosphorylate and degrade IκB, and then activate NF-κB in 
rat vascular smooth muscle cells. These results suggest that cerulein induces 
the activation of not only NF-κB, but also AP-1 through ERK signaling 
pathways. 
It is well known that cerulein induces inflammatory signaling in pancreatic 
acinar cells through its interaction with CCK-A or CCK-B receptor. However, 
it was recently reported that the pancreas possesses a local renin-angiotensin 
system, which performs various activities in the regulation of exocrine and 
endocrine functions of the pancreas27. In the exocrine pancreas, both 
angiotensin II type 1 receptor and angiotensin II type 2 receptor are localized 
in the pancreatic ducts and acinar cells. Indeed, renin-angiotensin system 
components are present in AR42J cell line as well as isolated acinar cells 26. 
Available data suggest that a local RAS in the exocrine pancreas should be 
involved in the regulation of pancreatic microcirculation, acinar enzyme 
secretion, and ductal anion secretion via mediation of angiotensin II type 2 
receptor26, 27.  Interestingly, pancreatic inflammatory conditions such as 
pancreatitis, hypoxia, and fibrosis can upregulate the renin-angiotensin system 
components in the pancreas, leading to further inflammation and tissue 
injury13, 26. In 1991, it was published that key components for inflammation 
comprise an intrinsic renin-angiotensin system within the canine pancreas32. 
Subsequent studies by other investigators reported comparable findings in the 
rat, mouse and human pancreas. Indeed, it was shown that the AR42J cell line 
expresses all components of an renin-angiotensin system including renin, 
angiotensinogen, angiotensin converting enzyme (ACE), angiotensin II type 1 
receptor and angiotensin II type 2 receptor. Thus, these cells may be of 
particular value to study the interplay of the angiotensin II type 1 receptor and 
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angiotensin II type 2 receptor in regulation of cell growth and potentially 
exocrine function26. 
In present study, cerulein increased membrane translocation of VEGF-D and 
interaction of VEGF-D with angiotensin II type 2 receptor in AR42J cells. 
This result indicates that VEGF-D, in conjunction with angiotensin II type 2 
receptor, may play an important role in cerulein-induced pancreatitis52. It was 
previously reported in our laboratory that inflammatory cytokine expression is 
mediated by NF-κB in cerulein-stimulated pancreatic acinar AR42J cells51. 
Present study demonstrates that cerulein-induced cytokine expression is 
mediated by Ras- AP-1- NF-κB signaling in cerulein-stimulated AR42J cells. 
Additionally, this study provides evidence that both VEGF-D and angiotensin 
II type 2 receptor play significant roles in inflammatory signaling of AR42J 
cells. Levels of VEGF-D in membrane, and its interaction with angiotensin II 
type 2 receptor were increased by cerulein. Inhibition of membrane 
translocation of VEGF-D by its antisense-oligodeoxynucleotide suppressed 
activations of NF-κB and AP-1, MAP kinase phosphorylation and cytokine 
expression in cerulein-stimulated AR42J cells. Furthermore, cerulein-induced 
cytokine expression was inhibited by angiotensin II type 2 receptor antagonist 
but not by VEGF-D receptor antagonist. These results suggest that angiotensin 
II type 2 receptor and VEGF-D are involved in cerulein-induced cytokine 
expression in pancreatic acinar AR42J cells. Therefore, this study suggests 
that VEGF-D induces novel cerulein-induced pancreatits pathway via 
interaction with angiotensin II type 2 receptor. VEGF-D-activated angiotensin 
II type 2 receptor may have a novel role in the development of pancreatitis. 
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V. CONCLUSION 
 
Cerulein pancreatitis is similar to human acute pancreatitis with 
dysregulation of the digestive enzyme production and cytoplasmic 
vacuolization, the death of acinar cells, edema formation, and infiltration of 
inflammatory cells into the pancreas. In this study, we identified several 
differentially expressed proteins in cerulein-stimulated AR42J cells, which are 
related to cellular stress, cytoskeletal function, and cell signaling. Among 
these proteins, VEGF-D is involved in regulation of inflammatory signaling in 
pancreatic AR42J cells. The present study demonstrated that VEGF-D binds 
angiotensin II type 2 receptor and controls cytokine expression in pancreatic 
AR42J cells. Moreover we showed that VEGF-D mediates cerulein-induced 
inflammatory signaling such as NF-κB and AP-1 through interaction with 
angiotensin II type 2 receptor. In conclusion, this study suggests that VEGF-D 
is involved in new cerulein-induced pancreatits pathway via the interaction 
with angiotensin II type 2 receptor in pancreatic acinar cells. VEGF-D-
activated angiotensin II type 2 receptor may have a novel role in the 
development of pancreatitis. 
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Abstract (in Korean) 
 
췌장 선세포에서의 급성 췌장염 유발에 대한 Angiotensin II 
type 2 수용체 및 VEGF-D 에 대한 역할 규명 
 
(지도교수 : 김 경 환) 
 
연세대학교 의과대학 의과학과 
 
이 장 원 
 
급성 췌장염은 최근의 많은 기초적, 임상적 연구에도 불구하고 
아직까지도 높은 사망률을 보이며 정확한 병리기전은 잘 알려져 
있지 않은 실정이다. Cholecystokinin 유도체인 cerulein은 빠른 
시간에 인체 급성 췌장염에서 볼 수 있는 췌장효소의 과잉 분비를 
유도하여, 급성 췌장염 징후 현상들(췌장의 부종, 선세포의 
vacuolization, 혈청 amylase와 lipase의 증가, 출혈 및 조직의 
괴사)을 나타내므로, cerulein 유도 급성 췌장염 모델은 
급성췌장염의 모델로써 널리 사용되고 있다.  
본 연구에서는 cerulein의 처치에 의하여 급성 췌장염을 
유발시킨 췌장선세포주인 AR42J 세포를 이용하여 췌장염 유발에 
의한 angiotensin II type 2 수용체 활성화의 기전에 대하여 VEGF-
D의 상호관련성을 규명하여 급성 췌장염 유발에 대한 angiotensin 
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II type 2 수용체 활성에 대한 새로운 기전을 규명하고자 하였다. 
췌장염의 발생 기전에 대한 예비실험으로서 cerulein을 처치한 
AR42J 세포주에서 막단백질을 분리한 후 2D gel 전기영동법을 
사용하여 이들 단백질들을 분석하여 본 결과 여러 세포막의 
단백질의 발현량의 변화를 관찰하였는데, 이 중 VEGF-D 단백질이 
증가함을 보였다. 다른 세포의 염증관련 신호전달체계에서 
혈관내피세포성장인자로 알려진 이 단백질은 angiogenesis에서의 
성장인자 및 ERK1/2 활성화에 영향을 주는 것으로 알려져 있다. 
최근 연구 결과, 또 다른 rennin-angiotensin 계의 요소인 
angiotensin II type 2 수용체가 췌장에서의 존재가 확인되어 이 
단백질도 cerulein 유도 췌장염 유발의 신호전달체계에 관여하고 
있음을 시사하고 있다. 또한 췌장염은 angiotensin II type 2 
수용체의 활성화에 의한 MAP kinase인 ERK1/2 활성에 의하여 
유발된다고 알려졌다. 게다가 VEGF-D가 이 angiotensin II type 2 
수용체와 단백질 결합을 통하여 염증을 유발한다는 보고는 있지만, 
염증 초기 단계의 췌장염에서의 조절기전에 대해서 명확한 결과를 
제시하지 못하고 있어, 그 체계적인 연구가 아직까지 미미한 
실정이다. 
본 실험 결과, cytokine의 발현은 ERK1/2 또는 MEK1의 길항제와 
마찬가지로 IκB 변종, RasN-17 또는 TAM67 같은 dominant 
negative 유전자에 의하여 억제됨을 보아, cerulein 유도 염증 
유발에는 NF-κB, AP-1와 ERK1/2가 관여함을 알 수 있다. 또한, 
cerulein에 의한 NF-κB and AP-1에 대한 DNA 결합 활성도는 
ERK1/2의 길항제에 의하여 억제됨을 보아, NF-κB and AP-1에 대한 
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DNA 결합 활성도는 ERK에 의한 신호전달체계에 의해 매개됨을 
시사한다. 
Cerulein에 의하여, 세포막에서의 VEGF-D의 양적 증가와, VEGF-
D와 angiotensin II type 2 수용체의 상호간 단백결합이 이루짐을 
관찰할 수 있었다. VEGF-D의 antisense-oligodeoxynucleotide을 
세포내로 transfection 시키어 VEGF-D의 세포막 이동을 억제시키면 
NF-κB and AP-1에 대한 DNA 결합 활성도와, MAP kinases의 인산화, 
IL-6 발현이 억제되는 것으로 보아, VEGF-D의 cerulein에 의한 
세포막 이동이 중요한 역할을 할 것으로 보인다. 또한, 
cerulein으로 유도된 cytokine 발현은 VEGF-D 수용체 억제제가 
아닌 angiotensin II type 2 수용체의 억제제에 의하여 
감소되었음을 보였다. 결론적으로 지금까지의 췌장염 병인 연구의 
결과에 의하면 cerulein의 자극으로 cholecystokinin 수용체의 
활성화를 통하여 친염증성 cytokine의 발현하는 신호전달체계 외에, 
cerulein에 의한 VEGF-D와 세포막의 angiotensin II type 2 
수용체의 결합을 통하여 친염증성 cytokine의 발현으로 이루어지는 
새로운 신호전달체계가 존재한다고 생각된다. 
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